智通财经5月16日晚间新闻精选 3、香港恒生指数将加入美的集团和中通快递。比亚迪将加入香港恒生科技指数，剔除阅文集团。 4、易方达公告，知名基金经理张坤因工作调整不再担任副总经理的高管职务，未来将专注于投资管理 工作。 1、证监会鼓励私募基金参与上市公司并购重组，首次建立简易审核程序；首次调整发行股份购买资产 的监管要求；首次建立分期支付机制；首次引入私募基金"反向挂钩"安排。 5、金力泰：董事会不同意股东提议召开临时股东大会。20CM两连板拓新药业：伊沃斯于2025年3月14 日至5月15日累计减持131.28万股。泰凌微：国家大基金持股比例降至6.95%。2连板丽人丽妆：麦角硫 因产品收入占比很低。隧道股份：控股股东拟2.5亿元-5亿元增持公司股份。宁德时代公布H股发售价： 厘定为每股H股263.00港元。 2、多位公募业内人士表示，近日关于公募考核基准导致市场调仓的有关分析不准确、不专业，缺乏基 本常识和依据。 ...

金力泰：董事会不同意股东提议召开临时股东大会 智通财经5月16日电，金力泰(300225.SZ)公告称，公司董事会收到股东海南大禾提议召开2025年第二次 临时股东大会的函，提议对非独立董事进行补选。董事会审议后认为，第一大股东海南大禾股权归属存 在纠纷，且公司2024年年度报告披露已超过法定期限，现任董事会及管理层需集中精力推动年报编制。 此外，被提名的非独立董事缺乏与公司核心业务相关的行业经验，可能影响董事会决策的专业性。因 此，董事会决定不同意召开临时股东大会。 ...

证券代码：300225 证券简称：金力泰 公告编号：2025-027 上海金力泰化工股份有限公司 第八届董事会第五十四次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 本次会议与会董事经过认真审议，通过如下决议： 1、审议未通过《关于股东提议召开临时股东大会的议案》 公司董事会于 2025 年 5 月 7 日收到海南大禾企业管理有限公司（以下简称 "海南大禾"）发来的《关于提议召开上海金力泰化工股份有限公司 2025 年第二 次临时股东大会的函》。海南大禾提请公司董事会尽快召开 2025 年第二次临时股 东大会并对非独立董事进行补选。同时要求审议以下议案： 1.《关于选举第八届董事会非独立董事的议案》 1、上海金力泰化工股份有限公司（以下简称"公司"）于 2025 年 5 月 14 日 以电子邮件的方式发出了召开第八届董事会第五十四次（临时）会议的通知，定 于 2025 年 5 月 16 日召开第八届董事会第五十四次（临时）会议。 2、本次董事会会议应出席董事 5 名，实际出席董事 5 名；本次董事会会议 于 20 ...

之 法律意见书 二〇二五年五月 上海市海华永泰律师事务所 关于上海金力泰化工股份有限公司 不同意股东提议召开临时股东大会 地址：上海市浦东新区陆家嘴环路 1366 号富士康大厦 12 层 邮编：200120 网址: www.hiwayslaw.com 电话：021-58773177 传真：021-58773268 1 对于本法律意见书的出具，本所律师特作如下声明： （一）本所及本所律师依据《证券法》《执业办法》和《执业规则》等规定 及本法律意见书出具之日以前已经发生或者存在的事实，严格履行了法定职责， 遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见书所 认定的事实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记 载、误导性陈述或者重大遗漏，并承担相应法律责任； （二）本所律师仅对金力泰本次关于公司董事会对股东海南大禾提议召开公 司 2025 年第二次临时股东大会有关的法律专业事项发表意见，对于其他问题本所 律师不发表意见； （三）本所律师同意将本法律意见书作为公司董事会对股东海南大禾提议召 开公司 2025 年第二次临时股东大会相关事项的法律文件，随其他披露材料一起上 2 致： ...

证券代码：300225 证券简称：金力泰 公告编号：2025-028 上海金力泰化工股份有限公司 关于董事会收到公司股东提议召开临时股东大会的函 暨董事会回复意见的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股东提议召开临时股东大会的基本情况 2025 年 5 月 7 日，上海金力泰化工股份有限公司（以下简称"公司"、"金 力泰公司"）董事会收到公司股东海南大禾企业管理有限公司（以下简称"海南 大禾"）发来的《关于提议召开上海金力泰化工股份有限公司 2025 年第二次临 时股东大会的函》（以下简称"《函》"），《函》主要内容如下： 公司于 2025 年 4 月 18 日披露了《关于董事、高级管理人员辞职的公告》， 于 2024 年 12 月 27 日、2023 年 3 月 15 日、2023 年 3 月 13 日披露了《关于董事 辞职的公告》。 根据《中华人民共和国公司法》《上市公司股东会规则》《上海金力泰化工 股份有限公司股东大会议事规则》及《上海金力泰化工股份有限公司章程》等规 定，为进一步完善金力泰公司的公司治理、更加有效地行使股东的监督权 ...

Core Viewpoint - The company, Shanghai Jinlitai Chemical Co., Ltd., is unable to disclose its 2024 annual report and the first quarter report of 2025 by the legal deadline of April 30, 2025, due to incomplete verification procedures related to financial information, which may lead to a risk warning for delisting [1][2][3] Progress Update - The company is actively working to complete the audit of the 2024 financial statements and is coordinating with the accounting firm to ensure timely and complete provision of necessary materials [2][5] - As of May 12, 2025, the company has not disclosed the 2024 annual report, and if it fails to do so within two months of the stock suspension, a delisting risk warning will be implemented [3] Potential Delisting Risk - The company’s stock has been suspended since May 6, 2025, and if the 2024 annual report is not disclosed within two months of this suspension, the Shenzhen Stock Exchange will decide to terminate the company's stock listing [3][4]

上海金力泰化工股份有限公司 证券代码：300225 证券简称：金力泰 公告编号：2025-026 2、根据《深圳证券交易所创业板股票上市规则》的相关规定，公司股票已 自 2025 年 5 月 6 日开市起停牌。若公司在股票停牌后两个月内仍未披露 2024 年 年度报告，公司股票交易将被实施退市风险警示；若公司在股票交易被实施退市 风险警示之日起的两个月内仍未披露 2024 年年度报告，深圳证券交易所将决定 终止公司股票上市交易。 公司原定于 2025 年 4 月 30 日披露 2024 年年度报告和 2025 年第一季度报 告。在公司 2024 年年度报告的编制及审计过程中，因涉及年度报告中财务信息 等相关重要事项未能完成核实查证程序，需公司与相关方进行多轮协调沟通，目 前相关工作仍在推进中，以上情况导致公司不能将 2024 年年度报告及 2025 年第 一季度报告依次提交至审计委员会、董事会审议。因此公司无法在法定期限内 关于定期报告披露进展暨股票交易可能被实施退市风险警 示的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、 ...

Core Viewpoint - The company Jinlitai (300225.SZ) is facing significant legal and regulatory challenges due to past false commitments made by its executives, leading to investor lawsuits and stock price declines [1][7][10]. Group 1: Legal Issues - Jinlitai is being sued by over a hundred investors for failing to fulfill a 300 million yuan share buyback commitment made by former executives, resulting in a landmark court ruling that mandates compensation for investors [1][7][10]. - The Shanghai Financial Court ruled that the executives' failure to execute their buyback promise constituted false representation, setting a precedent for similar cases in China [7][10]. - The total compensation sought by investors has reached over 52 million yuan, indicating widespread dissatisfaction among shareholders [1][10]. Group 2: Regulatory Scrutiny - The company is under investigation by the China Securities Regulatory Commission (CSRC) for violations related to its 2024 annual report and 2025 quarterly report, leading to a temporary suspension of its stock [1][2]. - Jinlitai has a history of false disclosures, having previously been penalized by the CSRC for misleading financial statements related to a fictitious gold trading business [2][3]. - The company reported significant discrepancies in its financial data, including inflated inventory and revenue figures, which have raised concerns about its financial integrity [3][4]. Group 3: Financial Performance - For 2024, Jinlitai reported total revenue of 732 million yuan, a slight decrease of 0.44% year-on-year, while net profit attributable to shareholders was 30.91 million yuan, an increase of 115.66% [5]. - The company anticipates a net profit of between 4.5 million and 6.5 million yuan for the first quarter of 2025, representing a year-on-year growth of 71% to 147% [5][6].

Investment Rating - The report does not explicitly state an investment rating for the chemical industry, but it provides detailed insights into market performance and trends, indicating a cautious outlook for certain segments [2][11]. Core Insights - In April 2025, the basic chemical index decreased by 3.61%, ranking 20th among primary industries, with various sub-sectors experiencing different levels of performance [11][16]. - The apparent consumption of methanol in China has surpassed 100 million tons for the first time, indicating significant growth in demand [2]. - The report highlights a notable increase in the prices of key chemical products, particularly trichloroethylene, which rose by 16.28% due to supply constraints and strong demand in the refrigerant market [24][25]. Market Overview - Major indices in April 2025 showed declines: Shanghai Composite Index -1.70%, Shenzhen Component Index -5.75%, and ChiNext Index -7.40% [11]. - Among the basic chemical sub-sectors, the rubber and products segment saw a significant decline of 13.52%, while daily chemicals and inorganic salts experienced growth of 8.56% and 4.37%, respectively [16][20]. Product Price Movements - The top ten products with price increases included trichloroethylene (16.28%), ammonium sulfate (12.20%), and H acid (10.96%) [24][30]. - Conversely, the products with the largest price declines included TMA (-28.26%), bromine (-24.14%), and vitamin A (-18.07%) [30][32]. Company Performance - In April 2025, 221 basic chemical companies reported positive returns, while 319 companies experienced negative returns [20]. - The top-performing companies included United Chemical with a 159.09% increase and Hongbaoli with a 104.27% increase in stock price [21][22]. Industry Trends - The report notes that the chemical raw materials and products manufacturing industry achieved a total profit of 78.76 billion yuan in the first quarter, reflecting a slight decline of 0.4% year-on-year [34]. - Shandong province is focusing on enhancing its chemical industry advantages, with significant growth in the number of large-scale chemical enterprises and revenue generation [34].

Investment Rating - The report does not explicitly state an investment rating for the chemical industry Core Insights - In April 2025, the basic chemical index decreased by 3.61%, ranking 20th among primary industries, with 12 sub-industries showing growth and 20 experiencing declines [11][16][20] - The apparent consumption of methanol in China has surpassed 100 million tons for the first time [1] Market Overview - Major indices in April 2025 showed the following changes: Shanghai Composite Index -1.70%, Shenzhen Component Index -5.75%, ChiNext Index -7.40%, and North Securities 50 Index +4.72% [11] - The basic chemical sector's performance was mixed, with significant declines in rubber and related products, while daily chemical products and inorganic salts showed positive growth [16][20] Product Price Movements - The top ten products with price increases in April 2025 included Trichloroethylene (+16.28%), Ammonium Sulfate (+12.20%), and H Acid (+10.96%) [24][25] - Trichloroethylene prices rose significantly due to reduced production and strong demand in the refrigerant market [25][26] Sub-Industry Performance - Among the basic chemical sub-industries, the top five performers were daily chemicals (+8.56%), inorganic salts (+4.37%), and fluorochemicals (+3.46%), while polyurethane and tires saw the largest declines of -17.59% and -14.68%, respectively [16][19] - In April 2025, 221 companies in the basic chemical sector reported positive returns, while 319 reported negative returns [20] Company Performance - The top ten companies by monthly growth included United Chemical (+159.09%), Hongbaoli (+104.27%), and Zhongxin Fluorine Materials (+65.92%) [21][22] - Conversely, the bottom ten companies included Hunan YN (-22.18%), Dingjide (-22.54%), and Hengxing New Materials (-23.21%) [23][24] Industry News - In the first quarter of 2025, the chemical raw materials and products manufacturing industry achieved a total profit of 78.76 billion yuan, a slight decrease of 0.4% year-on-year [32] - Shandong province continues to enhance its chemical industry advantages, with 3,682 large-scale chemical enterprises and a revenue of 2.86 trillion yuan by the end of 2024 [32]